NAEVR praises champions for $10 billion funding boon

Article

With the enactment of the American Recovery and Reinvestment Act of 2009 (HR 1) in Denver, the National Alliance for Eye and Vision Research praised Congress and biomedical research champions that facilitated the $10 billion in funding for the National Institutes of Health.

Key Points

Washington, DC-With the enactment of the American Recovery and Reinvestment Act of 2009 (HR 1) in Denver, the National Alliance for Eye and Vision Research (NAEVR) praised Congress and biomedical research champions that facilitated the $10 billion in funding for the National Institutes of Health (NIH).

James Jorkasky, executive director of NAEVR, said, "NAEVR was pleased to support the efforts of Senators Tom Harkin (D-IA), Arlen Specter (R-PA), Richard Durbin (D-IL), and Majority Leader Harry Reid (D-NV) in the Senate, and Speaker Nancy Pelosi (D-CA) and Appropriations Committee Chair David Obey (D-WI) in the House, to include $10 billion in funding for the NIH. We thank them for their commitment to biomedical research and its power to create and sustain jobs through this economic stimulus bill. We also owe a great deal to Maine's Republican Sens. Nancy Collins and Olympia Snowe, who joined with Sen. Specter in demonstrating independence and leadership in ensuring that this measure passed in the Senate."

Jorkasky pointed out that the funding will create 70,000 jobs in the near term and will have an economic impact in every state, as NIH funding trickles down by supporting research at academic institutions nationwide.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Reviewing the State of Dry Eye Survey with Selina McGee, OD, FAAO, Dipl ABO
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
© 2025 MJH Life Sciences

All rights reserved.